Pathstone Holdings’s CureVac CVAC Stock Holding History

Pathstone Holdings’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,155	Closed	-$45.6K	–	2213
2025 Q1	$45.6K	Hold	16,155	–	–	﹤0.01%	2181
2024 Q4	$49.4K	Sell	16,155 -1,005	-6%	-$2.9K	﹤0.01%	2266
2024 Q3	$50.9K	Buy	17,160 +4,718	+38%	+$15.5K	﹤0.01%	2292
2024 Q2	$42.2K	Sell	12,442 -224	-2%	-$733	﹤0.01%	2271
2024 Q1	$38.4K	Sell	12,666 -160	-1%	-$562	﹤0.01%	2265
2023 Q4	$54.8K	Buy	+12,826	New	+$69.6K	﹤0.01%	2166

Other funds holding CVAC

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Pathstone Holdings's CVAC Position: Q2 2025 in Review

Pathstone Holdings sold out of CureVac (CVAC) in Q2 2025, closing a stake of 16,155 shares — an estimated $45.6K sold.

Pathstone Holdings first reported a position in CVAC in Q4 2023 and held it in 6 quarters. The position peaked at $54.8K in Q4 2023. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

Pathstone Holdings reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
Pathstone Holdings sold 16,155 CureVac shares in Q2 2025, an estimated $45.6K.
Pathstone Holdings first reported a position in CureVac in Q4 2023 and held it in 6 quarters.
Pathstone Holdings's CureVac position peaked at $54.8K in Q4 2023.
91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.